Biotech & Cell Therapy Commercialization Strategy
Translate breakthrough science into market-ready therapies with precision analysis of scalability, regulatory readiness, and competitive landscapes.
8 Articles in Biotechnology and Cell Biology
Pulse: AI-Driven Predictive Biomarkers from Multimodal Data
In the era of precision medicine, the "pulse" of human biology is no longer limited to the heartbeat or blood test; it is a rhythm understood through genes, images, behaviors and electronic footprints.
The Future of Microbiome-Based Therapies
Earlier, the leading causes of diseases were bacteria, tiny living organisms that had to be eradicated at all costs. However, these small creatures are now causing a significant shift in the field of medicine. Bacteria will be the scientific heroes of tomorrow. Since these are being genetically modified, kept in carriers that have been carefully made, and employed as medications.
Bioprinting for Kidney Disease
Renal Diseases Prevalence
AI-Driven Voice Biomarkers: Emerging Solution for Disease Management
AI-Driven Voice Biomarkers: Revolution in Non-Invasive Healthcare Diagnostics
Bioenergy with Carbon Capture Storage: Evolution, Projects and Path
Bioenergy with carbon capture and storage (BECCS) involves capturing and permanently storing carbon dioxide from processes where biomass is converted into fuels or burned directly to generate energy. Plants absorb carbon dioxide as they grow, a process that helps remove carbon dioxide from the atmosphere. BECCS is a vital technology that reduces greenhouse gas emissions while generating energy.
Bioelectronic Medicine: Growing Interest in Nerve Stimulation Treatments
For years, people believed that there was a pill for every condition. However, contrary to the usual pattern, our bodies have always spoken a different dialect. It is not a language of substances but of electric signals, millions of tiny impulses that control cardiac function and the rhythm of respiration and ensure that every cell is synchronized.
Global Initiatives on AMR (Antimicrobial Resistance): What It Means for Pharma Pipelines and Future Markets?
The phenomenon of antimicrobial resistance (AMR) poses a significant threat to human health. It has been weakening the effectiveness of medicine over the past few years, posing a serious challenge to both human and animal healthcare systems.
Bioprinting of Human Microtissue for Drug Testing
Drug development faces pressure to become faster, more predictive, and more human-relevant. The core problem is the apparent limitations in the way we test medication candidates before human trials. The primary issue with traditional testing methods, including 2D cell cultures and animal experiments, is their inability to replicate the dynamic biological processes that occur in human bodies.
